These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 27939884)
1. WIP promotes in-vitro invasion ability, anchorage independent growth and EMT progression of A549 lung adenocarcinoma cells by regulating RhoA levels. Salvi A; Thanabalu T Biochem Biophys Res Commun; 2017 Jan; 482(4):1353-1359. PubMed ID: 27939884 [TBL] [Abstract][Full Text] [Related]
2. MDA-9/Syntenin (SDCBP) modulates small GTPases RhoA and Cdc42 via transforming growth factor β1 to enhance epithelial-mesenchymal transition in breast cancer. Menezes ME; Shen XN; Das SK; Emdad L; Sarkar D; Fisher PB Oncotarget; 2016 Dec; 7(49):80175-80189. PubMed ID: 27863394 [TBL] [Abstract][Full Text] [Related]
3. WIP is necessary for matrix invasion by breast cancer cells. García E; Machesky LM; Jones GE; Antón IM Eur J Cell Biol; 2014 Oct; 93(10-12):413-23. PubMed ID: 25169059 [TBL] [Abstract][Full Text] [Related]
4. Cofilin-1 signaling mediates epithelial-mesenchymal transition by promoting actin cytoskeleton reorganization and cell-cell adhesion regulation in colorectal cancer cells. Sousa-Squiavinato ACM; Rocha MR; Barcellos-de-Souza P; de Souza WF; Morgado-Diaz JA Biochim Biophys Acta Mol Cell Res; 2019 Mar; 1866(3):418-429. PubMed ID: 30296500 [TBL] [Abstract][Full Text] [Related]
5. Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance. Kim YJ; Choi WI; Jeon BN; Choi KC; Kim K; Kim TJ; Ham J; Jang HJ; Kang KS; Ko H Toxicology; 2014 Aug; 322():23-33. PubMed ID: 24793912 [TBL] [Abstract][Full Text] [Related]
6. A peptide derived from the Wiskott-Aldrich syndrome (WAS) protein-interacting protein (WIP) restores WAS protein level and actin cytoskeleton reorganization in lymphocytes from patients with WAS mutations that disrupt WIP binding. Massaad MJ; Ramesh N; Le Bras S; Giliani S; Notarangelo LD; Al-Herz W; Notarangelo LD; Geha RS J Allergy Clin Immunol; 2011 Apr; 127(4):998-1005.e1-2. PubMed ID: 21376381 [TBL] [Abstract][Full Text] [Related]
7. PD-L1 promotes tumor growth and progression by activating WIP and β-catenin signaling pathways and predicts poor prognosis in lung cancer. Yu W; Hua Y; Qiu H; Hao J; Zou K; Li Z; Hu S; Guo P; Chen M; Sui S; Xiong Y; Li F; Lu J; Guo W; Luo G; Deng W Cell Death Dis; 2020 Jul; 11(7):506. PubMed ID: 32632098 [TBL] [Abstract][Full Text] [Related]
8. FLI1 Induces Megakaryopoiesis Gene Expression Through WAS/WIP-Dependent and Independent Mechanisms; Implications for Wiskott-Aldrich Syndrome. Wang C; Sample KM; Gajendran B; Kapranov P; Liu W; Hu A; Zacksenhaus E; Li Y; Hao X; Ben-David Y Front Immunol; 2021; 12():607836. PubMed ID: 33717090 [TBL] [Abstract][Full Text] [Related]
9. Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis. Wang H; Zhang H; Tang L; Chen H; Wu C; Zhao M; Yang Y; Chen X; Liu G Toxicology; 2013 Jan; 303():139-46. PubMed ID: 23146760 [TBL] [Abstract][Full Text] [Related]
10. Sanguiin H6 suppresses TGF-β induction of the epithelial-mesenchymal transition and inhibits migration and invasion in A549 lung cancer. Ko H; Jeon H; Lee D; Choi HK; Kang KS; Choi KC Bioorg Med Chem Lett; 2015 Dec; 25(23):5508-13. PubMed ID: 26508552 [TBL] [Abstract][Full Text] [Related]
11. Invadopodia proteins, cortactin, N-WASP and WIP differentially promote local invasiveness in ameloblastoma. Siar CH; Rahman ZA; Tsujigiwa H; Mohamed Om Alblazi K; Nagatsuka H; Ng KH J Oral Pathol Med; 2016 Sep; 45(8):591-8. PubMed ID: 26752341 [TBL] [Abstract][Full Text] [Related]
12. Intersectin adaptor proteins are associated with actin-regulating protein WIP in invadopodia. Gryaznova T; Kropyvko S; Burdyniuk M; Gubar O; Kryklyva V; Tsyba L; Rynditch A Cell Signal; 2015 Jul; 27(7):1499-508. PubMed ID: 25797047 [TBL] [Abstract][Full Text] [Related]
13. Ezrin is required for epithelial-mesenchymal transition induced by TGF-β1 in A549 cells. Chen MJ; Gao XJ; Xu LN; Liu TF; Liu XH; Liu LX Int J Oncol; 2014 Oct; 45(4):1515-22. PubMed ID: 25051016 [TBL] [Abstract][Full Text] [Related]
14. WIP: more than a WASp-interacting protein. Fried S; Matalon O; Noy E; Barda-Saad M J Leukoc Biol; 2014 Nov; 96(5):713-27. PubMed ID: 25210148 [TBL] [Abstract][Full Text] [Related]
15. FPPS mediates TGF-β1-induced non-small cell lung cancer cell invasion and the EMT process via the RhoA/Rock1 pathway. Lin L; Li M; Lin L; Xu X; Jiang G; Wu L Biochem Biophys Res Commun; 2018 Feb; 496(2):536-541. PubMed ID: 29337059 [TBL] [Abstract][Full Text] [Related]
16. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression. Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904 [TBL] [Abstract][Full Text] [Related]
17. New Structural Insights into Formation of the Key Actin Regulating WIP-WASp Complex Determined by NMR and Molecular Imaging. Halle-Bikovski A; Fried S; Rozentur-Shkop E; Biber G; Shaked H; Joseph N; Barda-Saad M; Chill JH ACS Chem Biol; 2018 Jan; 13(1):100-109. PubMed ID: 29215267 [TBL] [Abstract][Full Text] [Related]
18. WASP-interacting protein (WIP): working in polymerisation and much more. Antón IM; Jones GE; Wandosell F; Geha R; Ramesh N Trends Cell Biol; 2007 Nov; 17(11):555-62. PubMed ID: 17949983 [TBL] [Abstract][Full Text] [Related]
19. WIP Drives Tumor Progression through YAP/TAZ-Dependent Autonomous Cell Growth. Gargini R; Escoll M; García E; García-Escudero R; Wandosell F; Antón IM Cell Rep; 2016 Nov; 17(8):1962-1977. PubMed ID: 27851961 [TBL] [Abstract][Full Text] [Related]
20. Transglutaminase-2 induces N-cadherin expression in TGF-β1-induced epithelial mesenchymal transition via c-Jun-N-terminal kinase activation by protein phosphatase 2A down-regulation. Park MK; You HJ; Lee HJ; Kang JH; Oh SH; Kim SY; Lee CH Eur J Cancer; 2013 May; 49(7):1692-705. PubMed ID: 23290789 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]